About this trial
This study is designed to compare three different methods of pain control after laparoscopic gallbladder surgery (laparoscopic cholecystectomy). Although this surgery is minimally invasive, participants often experience different types of pain after the operation, such as pain at the incision site, pain inside the abdomen, and shoulder pain caused by the gas used during surgery.
The investigators will compare three commonly used pain relief techniques:
Local infiltration - injecting a numbing medicine (bupivacaine) into the gallbladder bed and at the sites where the surgical instruments are placed.
Erector spinae plane (ESP) block - an ultrasound-guided nerve block performed in the back to reduce both abdominal and incisional pain.
Intrathecal morphine - a very small dose of morphine given into the spinal fluid before surgery to provide long-lasting pain relief.
The goal is to determine which method provides the best pain control, reduces the need for opioid medications, and improves recovery after surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18-65 years
Scheduled for elective laparoscopic cholecystectomy
American Society of Anesthesiologists (ASA) physical status I-III
Able to provide written informed consent
Disqualifiers
Body mass index (BMI) > 35 kg/m²
History of coagulopathy or bleeding disorders
Known allergy or hypersensitivity to opioids or local anesthetics
Chronic pain or regular analgesic use
Trial design
Parallel
Treatments tested in this trial
Bupivacaine Infiltration
DrugAfter removal of the gallbladder, 40 mL of 0.25% bupivacaine will be applied to the gallbladder bed with a sterile sponge for 10-15 minutes. At the end of the surgery, 15 mL of 0.25% bupivacaine will be infiltrated into trocar insertion sites (5 mL umbilical port, 5 mL epigastric port, 5 mL each auxiliary port).
Erector Spinae Plane Block
Procedure/SurgeryBefore induction of anesthesia, a bilateral ultrasound-guided erector spinae plane block will be performed at the T7 transverse process level. A total of 40 mL of 0.25% bupivacaine will be injected (20 mL per side) using an in-plane technique under ultrasound guidance.
Intrathecal Morphine
DrugWith the patient in the sitting position, a 27-gauge spinal needle will be inserted at the L3-L4 interspace. A dose of 100 mcg morphine will be administered intrathecally before induction of anesthesia.
Treatment groups
Trial outcomes
Primary outcomes
Total Opioid Consumption in the First 24 Hours
The cumulative amount of opioid analgesic (fentanyl via patient-controlled analgesia device) used by each patient during the first 24 hours after laparoscopic cholecystectomy. This measure will evaluate the effectiveness of each intervention in reducing postoperative opioid requirement.
Secondary outcomes
Postoperative Pain Scores (Visual Analog Scale, VAS)
Pain intensity will be assessed using the Visual Analog Scale (VAS, 0-10 ; 0 = no pain, 10 = worst imaginable pain) during active (movement) and passive (rest) conditions.
Incidence of Postoperative Nausea and Vomiting (PONV)
Presence or absence of nausea and vomiting will be recorded to evaluate intervention-related side effects.
Incidence of Pruritus
Occurrence of itching will be recorded as a side effect possibly related to intrathecal morphine.
Incidence of Respiratory Depression
Respiratory depression will be defined as a respiratory rate \< 8 breaths/min or oxygen saturation \< 90% requiring intervention.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: